Tag: Basilea
Phase 3 Study of Antifungal Fosmanogepix for Candidemia & Invasive Candidiasis
Basilea Pharmaceutica Ltd, a biopharmaceutical company based in Allschwil, Switzerland, has recently announced the launch of the Fosmanogepix Against Standard-of-care Treatment in Invasive Candidiasis...
BREAKING NEWS
The Average Personal Debt Held by Australians: A Detailed Analysis
The personal debt landscape in Australia has been unveiled by Canstar, shedding light on the financial burdens carried by the average Aussie. Credit card...
